TransAlta Corporation

Fundamentals5.8
Price Action5.5
News Sentiment5.5
AI Rating
5.9

Key Drivers

  • Margin Expansion
  • Cash Flow Strength
  • Balance-Sheet Risk

AI
AI Summary

5.9

TAC now looks like an execution-and-capital-allocation story rather than a pure turnaround: the latest quarter shows real profit and cash generation, but with ~5x leverage, sub-1 liquidity, and dilution from the equity raise, per-share upside depends on sustaining margin gains while de-risking the balance sheet.

Execution‍
Leverage
CashFlow‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.8

Key Financial Insights:

  • Margin Expansion
  • Cash Flow Strength
  • Balance-Sheet Risk

TAC is improving operationally and generating solid cash flow, but high leverage, sub-1.0 liquidity, and thin interest coverage still make the equity case risky.

turnaround
leverage

Price Behavior

5.5
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Mid-June rebound
  • Range-bound trade
  • Momentum cooled

TAC has been choppy over the last month, rebounding from mid-June weakness but now stalling below the mid-$14s and sitting in a neutral range near $13.35-$13.85.

rangebound
cooling
Support Level: $13.35-$13.40
Resistance Level: $13.80-$13.85

Sharp early drop followed by a partial recovery and mild pullback

Sentiment & News

5.5

Key News Insights:

  • Equity financing
  • Unit 2 extension
  • Earnings date

TransAlta completed a $350 million equity raise, secured a 90-day extension for Centralia Unit 2 availability, and scheduled its Q2 2026 earnings release for July 31.

EquityRaise

The financing and operational update are supportive but neutral overall, with the upcoming Q2 results likely the main near-term catalyst